In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.
 
The paper is available here: <a href='https://doi.org/10.1111/dmcn.16482'>https://doi.org/10.1111/dmcn.16482</a>
 
Follow DMCN on Podbean for more:  https://dmcn.podbean.com/
___
Watch DMCN Podcasts on YouTube:
<a href='https://bit.ly/2ONCYiC'>https://bit.ly/2ONCYiC</a>
__
DMCN Journal:
Developmental Medicine &amp; Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.
 
DMCN Journal - <a href='https://onlinelibrary.wiley.com/journal/14698749'>https://onlinelibrary.wiley.com/journal/14698749</a>
___
Find us on Twitter!
@mackeithpress - <a href='https://twitter.com/mackeithpress'>https://twitter.com/mackeithpress</a>

<description>&lt;p&gt;In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;The paper is available here: &lt;a href='https://doi.org/10.1111/dmcn.16482'&gt;https://doi.org/10.1111/dmcn.16482&lt;/a&gt;&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;Follow DMCN on Podbean for more:  https://dmcn.podbean.com/&lt;/p&gt;
&lt;p&gt;___&lt;/p&gt;
&lt;p&gt;Watch DMCN Podcasts on YouTube:&lt;/p&gt;
&lt;p&gt;&lt;a href='https://bit.ly/2ONCYiC'&gt;https://bit.ly/2ONCYiC&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;__&lt;/p&gt;
&lt;p&gt;DMCN Journal:&lt;/p&gt;
&lt;p&gt;Developmental Medicine &amp;amp; Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.&lt;/p&gt;
&lt;p&gt; &lt;/p&gt;
&lt;p&gt;DMCN Journal - &lt;a href='https://onlinelibrary.wiley.com/journal/14698749'&gt;https://onlinelibrary.wiley.com/journal/14698749&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;___&lt;/p&gt;
&lt;p&gt;Find us on Twitter!&lt;/p&gt;
&lt;p&gt;@mackeithpress - &lt;a href='https://twitter.com/mackeithpress'&gt;https://twitter.com/mackeithpress&lt;/a&gt;&lt;/p&gt;
</description>

In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.
 
The paper is available here: https://doi.org/10.1111/dmcn.16482
 
Follow DMCN on Podbean for more:  https://dmcn.podbean.com/
___
Watch DMCN Podcasts on YouTube:
https://bit.ly/2ONCYiC
__
DMCN Journal:
Developmental Medicine &amp; Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.
 
DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749
___
Find us on Twitter!
@mackeithpress - https://twitter.com/mackeithpress

DMCN Journal

Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN

Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN

Description